These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22993281)

  • 21. Increased expression of serum Matrix Metalloproteinase-9 in patients with moyamoya disease.
    Fujimura M; Watanabe M; Narisawa A; Shimizu H; Tominaga T
    Surg Neurol; 2009 Nov; 72(5):476-80; discussion 480. PubMed ID: 19147196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RNA in blood is altered prior to hemorrhagic transformation in ischemic stroke.
    Jickling GC; Ander BP; Stamova B; Zhan X; Liu D; Rothstein L; Verro P; Khoury J; Jauch EC; Pancioli AM; Broderick JP; Sharp FR
    Ann Neurol; 2013 Aug; 74(2):232-40. PubMed ID: 23468366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood-brain barrier breakdown.
    Nag S; Venugopalan R; Stewart DJ
    Acta Neuropathol; 2007 Nov; 114(5):459-69. PubMed ID: 17687559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early increases in serum S100B are associated with cerebral hemorrhage in a rat model of focal cerebral ischemia.
    Tanaka Y; Marumo T; Omura T; Yoshida S
    Brain Res; 2008 Aug; 1227():248-54. PubMed ID: 18621038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.
    Ning M; Furie KL; Koroshetz WJ; Lee H; Barron M; Lederer M; Wang X; Zhu M; Sorensen AG; Lo EH; Kelly PJ
    Neurology; 2006 May; 66(10):1550-5. PubMed ID: 16717217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins.
    Ishihara H; Kubota H; Lindberg RL; Leppert D; Gloor SM; Errede M; Virgintino D; Fontana A; Yonekawa Y; Frei K
    J Neuropathol Exp Neurol; 2008 May; 67(5):435-48. PubMed ID: 18431253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia.
    Fujimoto M; Takagi Y; Aoki T; Hayase M; Marumo T; Gomi M; Nishimura M; Kataoka H; Hashimoto N; Nozaki K
    J Cereb Blood Flow Metab; 2008 Oct; 28(10):1674-85. PubMed ID: 18560439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Matrix metalloproteinase-9 contributes to the increase of tau protein in serum during acute ischemic stroke.
    Kurzepa J; Bielewicz J; Grabarska A; Stelmasiak Z; Stryjecka-Zimmer M; Bartosik-Psujek H
    J Clin Neurosci; 2010 Aug; 17(8):997-9. PubMed ID: 20627731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholesterol levels and risk of hemorrhagic transformation after acute ischemic stroke.
    D'Amelio M; Terruso V; Famoso G; Ragonese P; Aridon P; Savettieri G
    Cerebrovasc Dis; 2011; 32(3):234-8. PubMed ID: 21860236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood-brain barrier tight junction permeability and ischemic stroke.
    Sandoval KE; Witt KA
    Neurobiol Dis; 2008 Nov; 32(2):200-19. PubMed ID: 18790057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebral ischemia enhances tyrosine phosphorylation of occludin in brain capillaries.
    Kago T; Takagi N; Date I; Takenaga Y; Takagi K; Takeo S
    Biochem Biophys Res Commun; 2006 Jan; 339(4):1197-203. PubMed ID: 16338221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
    Liu LB; Xue YX; Liu YH; Wang YB
    J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unriddling the role of matrix metalloproteinases in human cerebral stroke.
    Hamann GF
    Stroke; 2003 Jan; 34(1):40-6. PubMed ID: 12515281
    [No Abstract]   [Full Text] [Related]  

  • 34. Elevated levels of troponins and acute ischemic stroke - a challenge for the cardiologist?
    Jensen JK; Mickley H
    Scand Cardiovasc J; 2007 Jun; 41(3):133-5. PubMed ID: 17487759
    [No Abstract]   [Full Text] [Related]  

  • 35. Magnetic resonance imaging characterization of hemorrhagic transformation of embolic stroke in the rat.
    Jiang Q; Zhang RL; Zhang ZG; Knight RA; Ewing JR; Ding G; Lu M; Arniego P; Zhang L; Hu J; Li Q; Chopp M
    J Cereb Blood Flow Metab; 2002 May; 22(5):559-68. PubMed ID: 11973428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ischemia-modified albumin and heart fatty acid-binding protein: could early ischemic cardiac biomarkers be used in acute stroke management?
    Herisson F; Delaroche O; Auffray-Calvier E; Duport BD; Guillon B
    J Stroke Cerebrovasc Dis; 2010; 19(4):279-82. PubMed ID: 20471858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-ischemic exercise reduces matrix metalloproteinase-9 expression and ameliorates blood-brain barrier dysfunction in stroke.
    Guo M; Cox B; Mahale S; Davis W; Carranza A; Hayes K; Sprague S; Jimenez D; Ding Y
    Neuroscience; 2008 Jan; 151(2):340-51. PubMed ID: 18160227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum total glutathione-S-transferase in stroke, a preliminary report.
    Samuel AM; Kollu R; Rao S; Rao A
    Clin Chem Lab Med; 2004; 42(8):984-6. PubMed ID: 15387456
    [No Abstract]   [Full Text] [Related]  

  • 39. Triggers and mediators of hemorrhagic transformation in cerebral ischemia.
    Wang X; Lo EH
    Mol Neurobiol; 2003 Dec; 28(3):229-44. PubMed ID: 14709787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemorrhagic transformation following ischemic stroke: significance, causes, and relationship to therapy and treatment.
    Lapchak PA
    Curr Neurol Neurosci Rep; 2002 Jan; 2(1):38-43. PubMed ID: 11898581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.